Avantor® opened its new biorepository and sample archiving facility in Europe. Located near the international airport in Frankfurt, Germany, the new facility enables researchers to have access to their samples for future research and analysis, or study validation, within 24 hours.
"The number of clinical trials to support research and development (R&D) of therapeutic modalities continues to grow rapidly across the globe. The associated samples and research materials require meticulous care and processing to ensure the validity of the clinical trial," said Christophe Couturier, Executive Vice President, Services at Avantor. "This critical need for speed and agility is only reinforced by the COVID-19 pandemic and the race to ensure safe and efficacious therapies – whether by testing previous discoveries or innovating new ones. Avantor can store samples at the end of a trial, and as vaccine production ramps up, we will be able to support manufacturers with their Bulk Drug Substance storage.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
Avantor's new biorepository and archiving facility in Germany has earned the internationally recognized DGNB "Gold" certification for sustainable construction, which helps to reduce cost intensive risks, while focusing on ecology, economy and sociocultural issues. This new facility complements the Company's U.S. landmark campus located in Leesburg, Va. and its other campus near Nice, France.